Healthcare Compliance

UMPJE Replaces Florida MPJE Effective June 1, 2026

The Florida Board of Pharmacy has amended Rule 64B16-26.200, Florida Administrative Code, adopting the Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE) effective June 1, 2026. The UMPJE assesses knowledge of state laws universal to all jurisdictions, replacing Florida's state-specific Multistate Pharmacy Jurisprudence Examination (also called the Florida Laws and Rules Examination). Beginning June 1, Florida will no longer administer its state-specific MPJE, and all Florida pharmacist licensure applicants must take the uniform examination through the National Association of Boards of Pharmacy.

Louisiana AG MFCU Secures Guilty Plea for Alexandria Man Who Forcefully Pushed and Shoved a Disabled Person

Louisiana Attorney General Murrill's Medicaid Fraud Control Unit secured a guilty plea from an Alexandria man on April 22, 2026. The defendant was charged with forcefully pushing and shoving a disabled person multiple times. The case was prosecuted as a state enforcement matter under the Medicaid Fraud Control Unit program, which investigates both financial fraud and patient abuse in Medicaid-funded facilities.

Mitchell Eye Center and Dr. Alan Mitchell Agree to Pay $415,000 to Resolve False Medicare Claims Allegations

Mitchell Eye Center, a Florida ophthalmology practice, and Dr. Alan Mitchell, an ophthalmologist and former owner, have agreed to pay $415,000 to resolve allegations under the False Claims Act. The United States alleges that from September 2018 through March 2020, the defendants caused the submission of false claims for transcranial doppler (TCD) tests to Medicare and the Veterans Health Administration. The settlement was announced on April 22, 2026, by the U.S. Attorney's Office for the District of Massachusetts.

Medicaid Fraud Control Unit Arrests Rapides Parish Man for Violence Against Disabled Resident

Attorney General Liz Murrill's Medicaid Fraud Control Unit arrested a Rapides Parish man for violently slamming a disabled resident, causing three fractured ribs. The arrest was carried out by state enforcement agencies in Louisiana on April 22, 2026. Healthcare facilities and providers should be aware that Medicaid Fraud Control Units investigate and prosecute patient abuse alongside fraud, and such enforcement actions may result in criminal prosecution and facility oversight implications.

Missouri Doctor Dr. Jonathan Wayne Morris Arrested on Healthcare Fraud and Illegal Prescribing Charges

Dr. Jonathan Wayne Morris, 46, of Columbia, Missouri, owner of Columbia Urgent Care, was arrested on April 22, 2026 following an indictment returned April 8, 2026 in U.S. District Court for the Eastern District of Missouri. He faces 15 counts of illegal prescribing of controlled substances and 23 counts of healthcare fraud. The indictment alleges that from May 1, 2019 through April 8, 2025, Morris caused Medicare and Medicaid to be billed for services allegedly provided by him when they were actually provided by unsupervised assistant physicians, who he allowed to train each other rather than providing required supervision.

Lehigh County Man Sentenced to Prison for Posing as a Medical Professional

A Lehigh County, Pennsylvania man was sentenced to state prison on April 22, 2026, after being convicted of posing as a medical professional without any medical training or licenses. The defendant administered care to patients in Carbon County, Pennsylvania, submitting fraudulent claims to Medicare, Medicaid, and private insurance companies for services he was not authorized to provide. The Pennsylvania Attorney General's Office prosecuted the case as a healthcare fraud and criminal impersonation matter.

Shreveport Woman Arrested for Unlicensed Medicaid Fraud Since 2019

Attorney General Liz Murrill's Medicaid Fraud Control Unit arrested a Shreveport woman on April 20, 2026, for providing medical services to patients without a license since at least 2019. The arrest stems from an investigation into unlicensed medical practice that resulted in Medicaid fraud. No specific penalty or restitution amount has been disclosed in the available records.

Iris Shaw Arrested for TennCare Fraud, 135 Overlapping Hours

A Memphis woman, Iris Shaw (DOB 12/4/85), has been arrested following a TennCare fraud investigation conducted by the Tennessee Bureau of Investigation Medicaid Fraud Control Division. The investigation, initiated in July 2025 based on a referral from BlueCare Special Investigations Unit, determined that between February 2024 and April 2025, Shaw submitted claims for 135 hours of overlapping caregiver services, constituting a violation of TennCare rules. The case represents an enforcement action by state authorities targeting Medicaid provider fraud.

Revises Annex 13 Under Pharmaceutical Affairs Act Article 102

The Taiwan Food and Drug Administration (TFDA) has revised Annex 13 of the list defining remote areas without pharmaceutical personnel under Article 102 of the Pharmaceutical Affairs Act (藥事法). This amendment modifies the geographic designations that determine where non-pharmacist personnel may legally practice pharmacy in areas lacking registered pharmaceutical professionals. The revision takes effect immediately upon issuance.

Georgia Board Disciplines Two Physicians with $10,000 Fines and Prescribing Coursework

The Georgia Composite Medical Board issued two public consent orders in March 2026 against physicians Marvin Pinzon, MD and James Seward, MD. The consent orders impose a $10,000 fine payable within 90 days of the docket date, along with a mandatory intensive prescribing course to be completed within the same timeframe. Both orders include a public reprimand and warn that failure to comply with the terms shall subject the respondent's license to further disciplinary action, including revocation. The board's authority derives from O.C.G.A. Title 43, Chapters 1 and 34, governing the practice of medicine in Georgia.

CMS PRA Notice: HCPCS Code Set Form, Comment Deadline May 26

CMS is seeking public comment on two Paperwork Reduction Act (PRA) information collection requests: a revision of the CMS HCPCS Modification to Code Set Form (CMS-10244, OMB control number 0938-1042) with 250 annual respondents and 2,500 total annual burden hours; and a reinstatement with change of the Conditions of Participation for Comprehensive Outpatient Rehabilitation Facilities (CORFs) (CMS-10282, OMB control number 0938-1091) covering 158 respondents and 1,260 annual burden hours, revised downward from 1,504 hours due to a decrease in certified CORFs from 188 to 155. Comments on both collections must be received by the OMB desk officer by May 26, 2026.

HCPCS Modification Comment Period Ends Today

Regulations.gov comment submission interface for CMS-2026-0530-0002, a CMS HCPCS modification rulemaking. The page provides a standard form for submitting public comments, with options for individual, organizational, or anonymous submission, and file attachment capabilities up to 20 files at 10MB each. No substantive details about the specific HCPCS modifications under consideration are contained in the page itself.

US12605728B2 Priming Cap, APTAR France, Granted Apr 21

US12605728B2 Priming Cap, APTAR France, Granted Apr 21

US Patent B2, Poly Medicure, Apr 21

US Patent B2, Poly Medicure, Apr 21

Finding Sexual and Reproductive Health and Rights Facts Fast: A New AI-Powered Tool

ChatHRP is a new AI-assisted beta-testing tool launched by HRP (the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction) to help policy-makers, experts, and health workers find verified sexual and reproductive health and rights information quickly. The tool uses advanced natural language processing and retrieval-augmented generation to connect users with precise, referenced content drawn exclusively from HRP and WHO research. With multilingual capabilities and low-bandwidth functionality, ChatHRP is designed for global usability including in low-resource settings.

Big Catch-Up Delivers Over 100 Million Childhood Vaccinations Across 36 Countries

The Big Catch-Up (BCU), a historic multi-year, multi-country effort launched during World Immunization Week 2023 to address pandemic-driven vaccination declines, has delivered over 100 million vaccine doses to an estimated 18.3 million children aged 1-5 across 36 countries. The initiative reached 12.3 million 'zero-dose children' who had never received a vaccine, and 15 million who had never received a measles vaccine, with programme implementation concluding on 31 March 2026. Despite meeting its target of reaching at least 21 million un- and under-immunized children, agencies warn that 14.3 million infants globally still missed at least one routine vaccine in 2024, and measles outbreaks of around 11 million cases in 2024 underscore persistent gaps in routine immunisation systems.

Digital Inclusion Ministerial Group Terms of Reference

The UK government has published terms of reference for the newly established Ministerial Group for Digital Inclusion. The group brings together eight government departments including DHSC, DSIT, DBT, MHCLG, HM Treasury, Cabinet Office, DCMS, DfE, and DWP. The group will work closely with the Department for Science, Innovation and Technology (DSIT). This is an administrative governance document establishing the framework and scope for the ministerial group, with no compliance obligations created for external parties.

UK Government Digital Inclusion Meeting Summaries Published

The UK government published transparency data containing meeting summaries from the cross-departmental Ministerial Group for Digital Inclusion, involving nine government bodies. The page provides access to summaries from meetings held on 21 January 2026 and 14 May 2025, published on 24 April 2026. This publication provides transparency into ministerial coordination on digital inclusion strategy but does not create compliance obligations for external organisations.

DHSC Staff Numbers and Costs, March 2026

The Department of Health and Social Care (DHSC) has published its monthly workforce management transparency data for March 2026. The published data includes reports on departmental staff numbers and payroll costs for both payroll and non-payroll staff. This transparency reporting is part of DHSC's ongoing commitment to publish departmental staff numbers and costs on a monthly basis, with the March 2026 data made publicly available on 24 April 2026.

National Advisory Council on Drug Abuse Meeting Notice, May 5, 2026

The National Institute on Drug Abuse announces a hybrid meeting of the National Advisory Council on Drug Abuse on May 5, 2026, with a closed session from 10:30 a.m. to 12:15 p.m. for grant review and evaluation, and an open session from 1:30 p.m. to 4:30 p.m. for council presentations and business. Interested persons may attend in person at the NIH Neuroscience Building in Rockville, MD, or virtually via NIH Videocast, and may submit written comments to Dr. Gillian Acca.

HHS OCR Requests Comment on Revised Form HHS-690 Civil Rights Assurance

HHS Office for Civil Rights (OCR) has submitted to OMB a revision of Information Collection 0945-0008, Form HHS-690 (Assurance of Compliance), which is open for public comment through May 26, 2026. The proposed revisions modify the definition of sex under Title IX and Section 1557 to conform to Executive Order 14168 and the court order in Texas v. Becerra (E.D. Tex. 2024), update statutory citations, add a definition of 'program or activity' per the Civil Rights Restoration Act, incorporate False Claims Act language, and clarify the form applies to both applicants and recipients of HHS federal financial assistance. Approximately 8,486 respondents will incur an estimated 33,944 annual burden hours at a total labor cost of $4,213,379.28.

CMS PRA Notice: HCPCS Code Set and CORF Information Collection Requests

CMS published a 30-day Paperwork Reduction Act notice announcing two information collection requests open for public comment through May 26, 2026. The first is a revision to the CMS HCPCS Modification to Code Set Form (CMS-10244, OMB Control No. 0938-1042) covering 250 annual responses and 2,500 annual burden hours from private-sector applicants seeking modifications to the Healthcare Common Procedure Coding System Level II code set. The second is a reinstatement with change of the Conditions of Participation for Comprehensive Outpatient Rehabilitation Facilities (CORFs), which enables CMS to verify CORF compliance with Medicare conditions specified at 42 CFR Part 485, Subpart B. Comments must be submitted via www.reginfo.gov/public/do/PRAMain.

Egis Pharmaceuticals, Withdrawal of Three ANDAs

FDA is withdrawing approval of three abbreviated new drug applications (ANDAs) — ANDA 060453 (Ambix Laboratories), ANDA 074748 (Egis Pharmaceuticals Ltd., Captopril tablets), and ANDA 074808 (Egis Pharmaceuticals Ltd., Piroxicam capsules) — effective April 24, 2026. The withdrawal is based on the holders' repeated failure to submit required annual reports pursuant to 21 CFR 314.81 and 314.98. The ANDA holders did not respond to FDA's Notice of Opportunity for Hearing (NOOH) published December 29, 2025, constituting a waiver of the opportunity for a hearing.

FDA Fiscal Year 2024 Annual Report on Drug and Biologics Postmarketing Requirements and Commitments

The Food and Drug Administration (FDA) is announcing the availability of its Fiscal Year 2024 annual report on the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs) required of, or agreed upon by, application holders of approved drug and biological products. The report covers PMRs/PMCs established in writing at the time of approval or after approval and includes: (1) the number of applicants with open PMRs/PMCs; (2) the number of open PMRs/PMCs; (3) the timeliness of applicant submission of annual status reports; (4) FDA-verified status of open PMRs/PMCs; (5) the status of closed PMRs/PMCs; and (6) distribution by fiscal year of establishment (FY2018 to FY2024). The report combines data from the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research.

NDI-1435 IMG-1 Original Notification

FDA received an original New Dietary Ingredient notification (NDI-1435) for the substance identified as IMG-1, filed under docket FDA-2025-S-0023-0128. The notification was submitted through regulations.gov as a pre-market safety filing required under 21 CFR Part 190.6. NDI notifications initiate FDA's 75-day review period during which the agency may determine whether the ingredient poses a safety concern, without formally approving or rejecting the filing.

Variance Approval Letter to Wasserman Live

FDA's Center for Devices and Radiological Health (CDRH) issued a variance approval letter to Wasserman Live. The specific terms, conditions, and scope of the variance are contained in the attachment, which is available as a downloadable PDF on regulations.gov under docket FDA-2026-V-2303-0003. Variance approvals granted under FDA regulations permit deviations from specific regulatory requirements under defined circumstances.

Suitability Petition From Hyman Phelps McNamara P.C.

A suitability petition has been filed with the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) by the law firm Hyman, Phelps & McNamara, P.C. The petition is available in two versions: a confidential business information attachment and a redacted version for public review on regulations.gov. The FDA will review the petition to determine whether it meets suitability requirements for the requested regulatory pathway.

Fluidization Device for Powdered Agent - EP4176912A2

The European Patent Office published EP4176912A2 on April 15, 2026, granting a European patent to Boston Scientific Scimed, Inc. for a fluidization device and powdered agent delivery system. The inventors are Andrew PIC, Joseph KING, Amanda SMITH, Jessica GRIMSBY, John FAVREAU, and Lauren LYDECKER. The patent covers IPC classifications A61M 11/02, A61M 31/00, A61M 13/00, and A61M 15/00, with designated states including DE, FR, GB, IT, NL, ES, and 23 other European jurisdictions.

Discharge Head for Liquid Dispenser Patent Application

The European Patent Office published patent application EP4338774A1 on April 15, 2026, filed by Aptar Radolfzell GmbH for a discharge head for a liquid dispenser. The invention is classified under A61M 15/00 and A61M 11/00, covering aerosol or spray dispenser mechanisms used in medical device applications. The patent designates multiple European contracting states, including Germany, France, Italy, and the United Kingdom.

EP4337288A1 Aerosol Device Adjustable Draw Resistance

The EPO published European patent application EP4337288A1, filed by JT International SA, covering an aerosol generation device with a manually adjustable resistance to draw mechanism. The application names Jaakko MCEVOY and Christoph LUNGENSCHMIED as inventors. International Patent Classifications A24F 40/48 and A61M 15/00 indicate the device spans smoking articles and medical aerosol delivery applications. The publication designates 39 contracting states across Europe, establishing a regional filing record.

European Patent EP4151261A1, Fisher & Paykel Healthcare, User Interface and System for Supplying Gases to an Airway

The European Patent Office granted patent EP4151261A1 to Fisher & Paykel Healthcare Limited on April 15, 2026, covering a user interface and system for supplying gases to an airway, with 17 named inventors including Holyoake, Cheung, Patel, Nouraei, and others. The patent covers respiratory and ventilation equipment including airway interfaces, gas delivery systems, and valve components classified under A61M medical device categories.

Otomagnetics European Patent Application for Magnetic Particle Alignment

The European Patent Office published application EP4333957A1 by Otomagnetics, Inc., covering methods for shaping magnetic fields to align forces on magnetic particles for patient anatomy and motion. The application was published on April 15, 2026, with inventor Benjamin Shapiro named. The designated states cover all EU member states plus associated countries.

Becton Dickinson Autoinjector European Patent EP4349385A1

The European Patent Office published application EP4349385A1 on April 15, 2026, designating Becton Dickinson France as the applicant and Michael Fiard as the inventor. The patent covers an autoinjector device for automatic injection of a product into an injection site, classified under A61M 5/32, with designations across 32 European states including Germany, France, and the United Kingdom.

European Patent EP4370184A1 Deoxyhemoglobin MRI Contrast Agent, Thornhill Scientific, Apr 15

The European Patent Office granted patent EP4370184A1 to Thornhill Scientific Inc. on April 15, 2026, covering a method of inducing deoxyhemoglobin as a contrast agent in a subject for magnetic resonance imaging. The patent names seven inventors and classifies under A61M (medical devices). The designated states cover all 27 EU member states plus several EEA and associated countries including the UK, Switzerland, Norway, Turkey, and others.

EPO Patent: Needle-Free Injection Cartridge, RWS GmbH

The European Patent Office has granted patent EP4359040A1 to RWS GmbH for an injection cartridge designed for a needle-free injection system. The patent application, filed by inventor Martin Klaumünzer, was published on April 15, 2026 and carries IPC classification A61M 5/30. The patent is designated valid in 35 European contracting states including Germany, France, the United Kingdom, and other EU member nations.

Therapeutic Gas Delivery Apparatus, Mallinckrodt, European Patent

The European Patent Office published European Patent Application EP4154930A1 for Mallinckrodt Pharmaceuticals Ireland Limited covering an apparatus to deliver therapeutic gas to a patient. The patent names five inventors: SCHNITMAN, MEDICIS, POTENZIANO, ACKER, and SCHMIDT, with IPC classifications covering respiratory therapy devices under A61M 16/00, 16/06, 16/08, 16/10, and 16/12. The application designates 31 European states including Germany, France, the United Kingdom, Italy, and Spain. This A1 publication indicates the EPO has accepted the application and made it publicly available following formal examination.

Method and Device for Checking Medical Functional Device Functions, Fresenius, EP4186539A1

The European Patent Office granted Fresenius Medical Care Deutschland GmbH a patent (EP4186539A1) on April 15, 2026 for a method and device for checking at least one function of a medical functional device. The inventors are Sören Gronau, Joachim Manke, Ralf Müller, and Ingo Schäfer, with the invention classified under A61M 1/16, A61M 1/34, and A61M 1/36. The patent designates 31 European states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Boehringer Ingelheim EP4039300A1 Nebulizer Patent

The EPO published patent application EP4039300A1 for a nebulizer and reservoir, filed by Boehringer Ingelheim International GmbH, designating 37 European states including all EU member states. The patent, classified under IPC A61M 15/00 and B05B 11/00, names inventors Eicher and Von Schuckmann and was granted on April 15, 2026. Patent holders gain enforceable intellectual property rights in all designated states, which may affect competitors developing similar inhalation drug delivery systems.

SiO2 Medical Products Syringe Patent EP4340908A1

The European Patent Office published patent application EP4340908A1 on April 15, 2026, titled 'Plungers, Plunger Assemblies, Syringes, and Methods of Making and Using Same.' The patent is assigned to SiO2 Medical Products, LLC with inventors Javier Ferrer and Brian Russell Lilly. The invention is classified under IPC A61M medical device categories covering syringe mechanisms and plunger assemblies. The patent designates 37 European states including Germany, France, Italy, Spain, and the United Kingdom.

Data Collection Tool for State Offices of Rural Health Program, OMB No. 0915-0322-Revision

HRSA is seeking public comment on a proposed revision to its data collection instrument for the State Offices of Rural Health Program (OMB No. 0915-0322-Revision). The notice, published in the Federal Register on April 24, 2026, invites feedback on the information collection before it is submitted to OMB. Comments must be submitted by May 26, 2026, a 32-day comment period.

MDHHS Seeks Public Comment on State Plan on Aging FY2027-2029

The Michigan Department of Health and Human Services Bureau of Aging, Community Living, and Supports has developed a draft State Plan on Aging for fiscal years 2027-2029 and is accepting public comments through May 21, 2026. The plan establishes four goals focused on enhancing access to services for older adults and caregivers, promoting inter-agency collaborations, improving information pathways, and using messaging that celebrates aging. Following the comment period, the finalized plan will be submitted to the Commission on Services to the Aging for approval at its June meeting before submission to the federal Administration for Community Living.

Anti-Bullying Grants for Students With Special Needs

MDHHS has issued a competitive Grant Funding Opportunity for schools and nonprofits to develop peer-to-peer anti-bullying programs for students with special healthcare needs at elementary and secondary schools. The $150,000 initiative will fund 30-35 awards, with programs based on the Statewide Autism Resources and Training model and targeting students with physical, developmental, behavioral or emotional conditions. Applications must be submitted by 3 p.m. May 22, 2026, with the grant period running October 1, 2026 through September 30, 2027. A pre-application conference will be held April 29, 2026 at 10:30 a.m.

Rabid Skunk Confirmed in Barnwell County; One Person Exposed

South Carolina DPH confirmed a skunk found near Marlboro Avenue between McDonald Drive and Dicks Circle in Barnwell, S.C. tested positive for rabies on April 21, 2026. One person was exposed and has been referred to their health care provider; no pets are known to have been exposed at this time. This is the first rabid animal case in Barnwell County in 2026, with 26 rabid animal cases confirmed statewide this year through April 21.

Foster Families Invited to Fostering Family Adventures Event at Massacre Rocks State Park Near American Falls

The Idaho Department of Health and Welfare and Idaho Department of Parks and Recreation are co-hosting Fostering Family Adventures at Massacre Rocks State Park on Saturday, May 2, 2026, from 1 p.m. to 4 p.m. The free event is open to foster families, kinship families, and community families, featuring outdoor activities including campfire skills, fishing basics, disc golf, wildflower and fossil exploration, reptile education, and Junior Ranger programming. The event aims to support and recognize foster families while providing educational outdoor recreation. Interested participants are asked to RSVP via EventBrite.

Boil Water Advisory Rescinded for Bourbon County RWD 2C

KDHE has rescinded the boil water advisory for the Bourbon Co RWD 2C public water supply system in Bourbon County, effective April 23, 2026. The advisory was originally issued due to a waterline break that caused loss of pressure in Fort Scott's distribution system, which may have resulted in bacterial contamination. Laboratory testing of drinking water samples confirmed no evidence of bacteriological contamination, and KDHE officials deemed all risk conditions resolved. The boil water advisory remains in effect for the City of Uniontown.

Apparatuses for Antegrade Transcatheter Valve Repair or Implantation

The USPTO has published patent application US20260108351A1, filed January 8, 2024, covering medical devices and systems for performing valve replacement or repair. The disclosed inventions include an outer catheter with one or more interchangeable inner catheters, a guidewire, and an expandable chordae tendinae deflector. The inner catheter may include a chordae tendinae deflector, and the outer catheter may be configured as a rapid pacing sheath. Named inventors are Tim A. FISCHELL and Frank SALTIEL. CPC classification is A61F 2/243.

Dual Anchor Prosthetic Heart Valve Device

Grant Matthew Stearns filed US Patent Application US20260108353A1 for a dual anchor prosthetic heart valve device with Application No. 19428239, filed December 21, 2025. The invention describes an implantable prosthetic device with two anchor portions configured to attach to native valve leaflets, where the anchors can be opened simultaneously by a single actuator or independently by multiple actuators.

Heart Valve Prostheses, Transcatheter Devices, and Methods

USPTO published patent application US20260108349A1 for heart valve prostheses and transcatheter devices filed by inventor Erik C. Griswold on August 18, 2025. The application covers an expandable anchoring frame with proximal and distal portions, an expandable stent frame with prosthetic valve structure mounted within, configured to capture native leaflets between the stent frame outer surface and anchoring frame inner surface. The patent has CPC classifications A61F 2/2418, A61F 2/2433, A61F 2/2436, and A61F 2250/0098.

SMP Foams Radially Expand to Seal Heart Valve Gaps

Landon D. Nash has filed USPTO Patent Application US20260108350A1 for individual shape memory polymer (SMP) foams that radially expand to seal gaps around heart valves that are improperly seated, have unusual cross sections, or have poor apposition against calcified lesions. The application, filed December 19, 2025 with application number 19426276, covers multiple CPC classifications related to foam materials and cardiac implants.

Valcare Medical Transcatheter Annuloplasty Patent

Valcare Medical, Inc. has published patent application US20260108352A1 for a transcatheter annuloplasty system and methods for treating valvular regurgitation. The application, filed October 20, 2025, covers an annuloplasty device with anterior and posterior anchors that transition from a constrained state to a deployed state, extending through windows into tissue at the native valve site. The system is designed for catheter-based delivery to manipulate the annuloplasty device within a patient's heart using a delivery handle to selectively deploy anchors while closing the anterior-to-posterior distance of the valve.